scholarly article | Q13442814 |
P356 | DOI | 10.1002/CNCR.21905 |
P698 | PubMed publication ID | 16649225 |
P50 | author | Naohiko Seki | Q90079422 |
P2093 | author name string | Osamu Yokosuka | |
Tatsuo Kanda | |||
Makoto Arai | |||
Takenori Ochiai | |||
Hiromitsu Saisho | |||
Tetsuhiro Chiba | |||
Fumio Imazeki | |||
Yuichi Takiguchi | |||
Mari Yatomi | |||
Kenichi Fukai | |||
Yuichi Hirasawa | |||
P2860 | cites work | Microtubules as a target for anticancer drugs | Q28253993 |
Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
Cancer epigenetics comes of age | Q29617275 | ||
FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes | Q29618118 | ||
Comparing gene expression profiles in human liver, gastric, and pancreatic tissues using full-length-enriched cDNA libraries | Q30980292 | ||
Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells | Q34124417 | ||
DNA methylation, chromatin inheritance, and cancer | Q34290318 | ||
The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy | Q34770609 | ||
Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma | Q35103214 | ||
Tumor cell invasion and survival in head and neck cancer | Q36078087 | ||
Number of CpG islands and genes in human and mouse | Q36738077 | ||
Gene expression profiles in liver regeneration with oval cell induction. | Q38342825 | ||
Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma. | Q40447611 | ||
Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate | Q40508930 | ||
Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer | Q40543809 | ||
Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells | Q41070371 | ||
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment | Q44155422 | ||
Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway | Q44512459 | ||
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies | Q44646952 | ||
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway | Q45215124 | ||
p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection | Q45659545 | ||
Identification and investigation of methylated genes in hepatoma | Q46505315 | ||
Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration | Q73469397 | ||
Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival | Q73847008 | ||
P433 | issue | 11 | |
P304 | page(s) | 2514-2525 | |
P577 | publication date | 2006-06-01 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-Aza-2'-deoxycytidine | |
P478 | volume | 106 |
Q45898301 | 5-AZA-2'-deoxycytidine (5-AZA-CdR) leads to down-regulation of Dnmt1o and gene expression in preimplantation mouse embryos. |
Q34428877 | 5-aza-2'-deoxycytidine leads to reduced embryo implantation and reduced expression of DNA methyltransferases and essential endometrial genes |
Q37035513 | Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment |
Q35121612 | DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer |
Q48009718 | GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition |
Q36412740 | Silver nanoparticles affect glucose metabolism in hepatoma cells through production of reactive oxygen species |
Search more.